Literature DB >> 29290044

Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.

Mario Giordano1, Amir Samii2,3, Rudolf Fahlbusch2.   

Abstract

We report our experience about somatotrophinomas without clinical manifestation of acromegaly having radiological- and surgical-verified invasion of the cavernous sinus. We present the clinical, radiological and hormonal status of three patients affected by invasive GH-secreting pituitary adenomas without clinical signs and symptoms of acromegaly with elevation of serum IGF-1 from a series of 142 pituitary adenomas operated in our institute with the aid of intraoperative magnetic resonance imaging (MRI). Total tumor removal was possible in two of the three cases; the patients show normal hormonal status and no recurrence at long-term follow-up. In the third case, due to the different features of the tumor, complete resection was not possible and a multimodal treatment was performed that allowed regularization of the hormonal status and control of the residual tumor. GH-secreting adenomas without clinical manifestation of acromegaly are uncommon lesions. Total microsurgical excision can be curative. However, in case of partial removal, a tailored adjuvant treatment should be considered to preserve the quality of life of the patient and avoid regrowth of the lesion. In not resectable tumors, preoperative medical treatment with somatostatin analogues is always an option.

Entities:  

Keywords:  GH; Neurosurgery; Silent pituitary adenoma; Somatotrophinoma

Mesh:

Substances:

Year:  2017        PMID: 29290044     DOI: 10.1007/s10143-017-0940-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  25 in total

1.  Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess.

Authors:  S Kalavalapalli; H Reid; J Kane; H Buckler; P Trainer; A H Heald
Journal:  Ann Clin Biochem       Date:  2007-01       Impact factor: 2.057

Review 2.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Corticolipotropin immunoreactivity in silent chromophobe adenomas: a light and electron microscopic study.

Authors:  J Hassoun; C Charpin; P Jaquet; J C Lissitzky; F Grisoli; M Toga
Journal:  Arch Pathol Lab Med       Date:  1982-01       Impact factor: 5.534

Review 4.  Silent pituitary adenomas.

Authors:  Sarah E Mayson; Peter J Snyder
Journal:  Endocrinol Metab Clin North Am       Date:  2014-11-06       Impact factor: 4.741

5.  Clinically silent somatotropinomas may be biochemically active.

Authors:  Alla A Sakharova; Eleni V Dimaraki; William F Chandler; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

6.  Morphological characterization and subtyping of silent somatotroph adenomas.

Authors:  H Naritaka; T Kameya; Y Sato; S Furuhata; M Otani; T Kawase
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.

Authors:  Laura Chinezu; Alexandre Vasiljevic; Jacqueline Trouillas; Marion Lapoirie; Emmanuel Jouanneau; Gérald Raverot
Journal:  Eur J Endocrinol       Date:  2016-11-15       Impact factor: 6.664

8.  Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.

Authors:  Savas Ceylan; Kenan Koc; Ihsan Anik
Journal:  J Neurosurg       Date:  2010-01       Impact factor: 5.115

9.  Efficacy and complications of neurosurgical treatment of acromegaly.

Authors:  Anna Krzentowska-Korek; Filip Gołkowski; Agata Bałdys-Waligórska; Alicja Hubalewska-Dydejczyk
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

10.  Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.

Authors:  Christian P Miermeister; Stephan Petersenn; Michael Buchfelder; Rudolf Fahlbusch; Dieter K Lüdecke; Annett Hölsken; Markus Bergmann; Hans Ulrich Knappe; Volkmar H Hans; Jörg Flitsch; Wolfgang Saeger; Rolf Buslei
Journal:  Acta Neuropathol Commun       Date:  2015-08-19       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.